LLC Synbio 3
3 · Xenetic Biosciences, Inc. · Filed Oct 27, 2017
Insider Transaction Report
Form 3
LLC Synbio
10% Owner
Holdings
- 821,567
Common Stock
- 970,000
Series A Preferred Stock
Warrants
Exercise: $25.41From: 2014-12-31Exp: 2019-12-30→ Common Stock (204,394 underlying)
Footnotes (1)
- [F1]The Reporting Person owns warrants exercisable into 204,394 shares of Common Stock. Such warrants are subject to performance vesting. The vesting milestones need to be achieved by December 31, 2017 (50%) and July 31, 2018 (50%). The amount of shares of Common Stock into which such warrants are exercisable was calculated for the purposes of this report without giving effect to any performance vesting limitations.